Table 1 Baseline characteristics of the study participants by sex and randomization status (intervention or usual care)
Women | Men | |||
|---|---|---|---|---|
Intervention n = 177 | Usual Care n = 190 | Intervention n = 81 | Usual Care n = 64 | |
Age (years), mean (SD) | 85.1 (6.62) | 85.1 (5.75) | 82.9 (6.59) | 83.4 (7.18) |
Living alone, n (%) | 149 (84) | 149 (78) | 53 (65) | 40 (63) |
Chronic diseases, n (%) | ||||
Cardiovascular diseases | 164 (93) | 174 (91) | 72 (89) | 60 (92) |
Diseases of musculoskeletal system | 115 (65) | 125 (65) | 43 (53) | 30 (46) |
Diabetes | 63 (36) | 66 (35) | 28 (35) | 26 (40) |
Cerebrovascular diseases | 48 (27) | 54 (28) | 35 (43) | 32 (49) |
Dementia | 62 (35) | 62 (33) | 23 (28) | 14 (22) |
Asthma or chronic obstructive pulmonary disease | 29 (16) | 41 (16) | 23 (28) | 12 (19) |
Psychiatric diseases | 34 (19) | 32 (17) | 15 (19) | 7 (11) |
Cancer | 24 (14) | 21 (11) | 22 (28) | 12 (19) |
Gastrointestinal diseases | 30 (17) | 28 (15) | 11 (14) | 8 (12) |
Neurological diseases | 23 (13) | 20 (11) | 13 (16) | 12 (19) |
Charlson Comorbidity Index, mean (SD) | 3.05 (2.48) | 2.65 (2.26) | 3.81 (3.09) | 3.22 (2.41) |
All medicinesa, mean (SD) | 15 (5.4) | 16 (5.2) | 15 (4.8) | 15 (4.6) |
Regularly taken | 9 (3.1) | 10 (3.0) | 10 (2.9) | 10 (3.1) |
Taken as needed | 3 (2.7) | 4 (2.6) | 4 (2.9) | 3 (2.2) |